Mostrar el registro sencillo

dc.contributor.authorAlonso González, Carolina 
dc.contributor.authorGonzález Abalde, Cristina
dc.contributor.authorMenéndez Menéndez, Javier
dc.contributor.authorGonzález González, Alicia
dc.contributor.authorAlvarez García, Virginia
dc.contributor.authorGonzález Cabeza, Alicia Verónica 
dc.contributor.authorMartínez Campa, Carlos Manuel 
dc.contributor.authorCos Corral, Samuel 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-03-22T13:46:13Z
dc.date.available2023-03-22T13:46:13Z
dc.date.issued2022-05-07
dc.identifier.issn2227-9059
dc.identifier.otherSAF2016-77103-P
dc.identifier.otherProyectos Puente 2020
dc.identifier.urihttps://hdl.handle.net/10902/28318
dc.description.abstractRadiation therapy is an important component of cancer treatment scheduled for cancer patients, although it can cause numerous deleterious effects. The use of adjuvant molecules aims to limit the damage in normal surrounding tissues and to enhance the effects of radiation therapy either killing tumor cells or slowing down their growth. Melatonin, an indoleamine released by the pineal gland, behaves as a radiosensitizer in breast cancer since it enhances the therapeutic effects of ionizing radiation and mitigates side effects on normal cells. However, the molecular mechanisms through which melatonin modulates the molecular changes triggered by radiotherapy remain mostly unknown. Here we report that melatonin potentiated the antiproliferative effect of radiation in MCF-7 cells. Treatment with ionizing radiation induced changes in expression of many genes. Out of a total of twenty-five genes altered by radiation, melatonin potentiated changes in thirteen of them, whereas reverted the effect in another ten cases. Among them, melatonin elevated the levels of PTEN and NME1, whereas counteracted the induction by radiation of SNAI2, ERBB2, AKT, SERPINE1, SFN, PLAU, ATM and N3RC1. We also analyzed the expression of several microRNAs and found that melatonin enhanced the effect of radiation on the levels of miR-20a, miR-19a, miR-93, miR-20b, miR-29a. Rather surprisingly, radiation induced miR-17, miR-141 and miR-15a but melatonin treatment prior to radiation counteracted this stimulatory effect. Radiation alone enhanced the expression of the cancer suppressor miR-34a, and melatonin strongly stimulated this effect. Melatonin further enhanced the radiationmediated inhibition of Akt. Finally, in an in vivo assay, melatonin restrained new vascularization in combination with ionizing radiation. Our results confirm that melatonin blocks many of the undesirable effects of ionizing radiation in MCF-7 cells and enhances changes that lead to optimed treatment resultses_ES
dc.description.sponsorshipAcknowledgments: The present study was funded by grants from the Spanish Economy and Competitiveness Ministry (SAF2016-77103-P), from Universidad de Cantabria (Proyectos Puente 2020) with the participation of the Consejería de Universidades, Igualdad, Cultura y Deporte del Gobierno de Cantabria, and from Instituto de Investigación Sanitaria Valdecilla (IDIVAL) (APG/12).es_ES
dc.format.extent21 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPI AGes_ES
dc.rightsAttribution 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceBiomedicines 2022, 10(5), 1088es_ES
dc.subject.otherMelatonines_ES
dc.subject.otherBreast canceres_ES
dc.subject.otherRadiotherapyes_ES
dc.subject.otherMCF-7 cellses_ES
dc.subject.otherGene expressiones_ES
dc.subject.othermiRNA expressiones_ES
dc.titleMelatonin modulation of radiation-induced molecular changes in MCF-7 human breast cancer cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/biomedicines10051088es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/biomedicines10051088
dc.type.versionsubmittedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International